Quick Answer
ATOSSA THERAPEUTICS, INC. reported Research And Development Expense of $21.19 million for the year ending 2025.
- ATOSSA THERAPEUTICS, INC. showed an increase of +50.1% in Research And Development Expense from 2024 to 2025.
- This data is from ATOSSA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2012 to 2025), ATOSSA THERAPEUTICS, INC.'s Research And Development Expense has grown by 973.2%.
- Historical annual values: Fiscal year 2025: $21.19 million | Fiscal year 2024: $14.12 million | Fiscal year 2023: $17.33 million | Fiscal year 2022: $15.08 million | Fiscal year 2021: $9.21 million | Fiscal year 2020: $6.61 million | Fiscal year 2019: $6.65 million | Fiscal year 2018: $4.21 million | Fiscal year 2017: $2.33 million | Fiscal year 2016: $770.4 thousand | Fiscal year 2015: $2.36 million | Fiscal year 2014: $1.11 million | Fiscal year 2013: $1.11 million | Fiscal year 2012: $1.97 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: